Issuance of Stock Acquisition Rights to Directors
First written in FY2019-Q1. 12 of 16 entries say "Advanced", first in FY2019. Latest entry: FY2027-H1.
107 other companies' latest entry also says "Advanced".
- FY2027-H1AdvancedAnnual report
「Series 27 Stock Acquisition Rights Date of resolution 9 April 2026 Classification and number of eligible grantees (people) Directors of the Company 4 Number of stock acquisition rights (rights) 122 Number of underlying shares (shares) 12,200」
Issued 122 Series 27 stock acquisition rights to 4 directors, equivalent to 12,200 common shares. - FY2026-H1RestatedAnnual report
「Series 26 Stock Acquisition Rights Date of resolution 11 April 2025 Classification and number of eligible grantees (people) Directors of the Company 4 Number of stock acquisition rights (rights) 99」
For the Series 26 stock acquisition rights, the interim report disclosed the issue of 99 rights to 4 directors, equivalent to 9,900 underlying shares. It also reported rights equivalent to 6,300 shares issued to 6 senior executive officers. - FY2025AdvancedAnnual report
「Stock Acquisition Rights, Series 26 for Directors The stock acquisition rights issued pursuant to a resolution of the Board of Directors dated 11 April 2025 are as follows.」
After the filing date, on 11 April 2025, Series 26 stock acquisition rights equivalent to 9,900 shares were issued to 4 directors and rights equivalent to 6,300 shares were issued to 6 senior executive officers. - FY2024AdvancedAnnual report
「Series 25 Stock Acquisition Rights The stock acquisition rights issued pursuant to a resolution of the Board of Directors dated 10 April 2024 are ... 3 directors of the Company ... Common shares: 10,300」
New Series 25 stock acquisition rights equivalent to 10,300 shares were granted to 3 directors, and stock acquisition rights equivalent to 8,400 shares were also issued to 7 senior executive officers. - FY2023AdvancedAnnual report
「Stock Acquisition Rights, Series 24 The stock acquisition rights issued pursuant to a resolution of the Board of Directors dated 12 April 2023 are as follows.」
As of the end of the month preceding the filing date, the disclosure reported the issue of 61 Series 24 stock acquisition rights for directors, equivalent to 6,100 common shares. - FY2023-Q1AdvancedAnnual report
「8 April 2022 Directors of the Company 4 80 Common shares 8,000 (Note 1)」
For the stock acquisition rights approved on 8 April 2022, 80 rights equivalent to 8,000 common shares were granted to 4 directors of the Company. - FY2022AdvancedAnnual report
「Stock Acquisition Rights, Series 22 Classification and number of eligible grantees 4 directors of the Company Number of stock options granted by class of shares (Note) Common shares: 8,000 shares」
Disclosed the grant of stock acquisition rights equivalent to 8,000 shares to 4 directors under the Series 22 stock acquisition rights approved on 9 April 2021. Before the filing date, Series 23 stock acquisition rights equivalent to 8,000 shares had also been issued. - FY2021-Q3AdvancedAnnual report
「14th Series Stock Acquisition Rights」
In connection with the merger, the disclosure sets out the underlying shares, exercise periods, issue prices and other details of Series 14 through Series 21 stock acquisition rights for former directors of マックスバリュ九州. - FY2020AdvancedAnnual report
「Stock Acquisition Rights, Series 13 The stock acquisition rights issued pursuant to a resolution of the Board of Directors dated 10 April 2020 are as follows.」
For the Series 13 stock acquisition rights, the disclosure states that they were approved on 10 April 2020 and comprised 99 rights, 9,900 underlying shares and an exercise period from 10 June 2020 to 9 June 2035, among other details. - FY2019AdvancedAnnual report
「Stock Acquisition Rights, Series 12 The stock acquisition rights issued pursuant to a resolution of the Board of Directors dated 10 April 2019 are as follows.」
For the Series 12 stock acquisition rights approved on 10 April 2019, the disclosure sets out the issue details, including 52 rights outstanding as of the end of the month preceding the filing date and 5,200 underlying shares. - FY2019-Q1First statedAnnual report
「The stock acquisition rights issued during the first quarter accounting period were as follows.」
For the 59 stock acquisition rights approved on 11 April 2018, the disclosure sets out the issue terms, including 5,900 underlying shares and an exercise period from 10 June 2018 to 9 June 2033.